We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Elexacaftor/tezacaftor/ivacaftor as rescue therapy in a patient with the cystic fibrosis genotype F508DEL/G1244E.
- Authors
Salvatore, Donatello; Colangelo, Carmela; D'Andria, Michele; Marsicovetere, Giovanni; Passarella, Domenica
- Abstract
Elexacaftor/tezacaftor/ivacaftor (ETI) is a cystic fibrosis (CF) transmembrane regulator (CFTR) modulator. It is known to be efficacious in stable patients with severe pneumopathy, but there are few data concerning its effectiveness during acute exacerbations. We here describe its use in a woman with CF and respiratory failure.
- Subjects
CYSTIC fibrosis; DISEASE exacerbation; RESPIRATORY insufficiency; CYSTIC fibrosis transmembrane conductance regulator; GENOTYPES
- Publication
Clinical Case Reports, 2021, Vol 9, Issue 8, p1
- ISSN
2050-0904
- Publication type
Case Study
- DOI
10.1002/ccr3.4713